George W. Torrance
Centre for Health Economics and Policy Analysis
McMaster University
Hamilton
Ontario
Canada
Name/email consistency: high
- Measuring quality of life: the development and initial validation of the patient-reported erectile function assessment instrument. Torrance, G.W., Keresteci, M.A., Casey, R., Ryan, N.C., Tarride, J.E. Int. J. Technol. Assess. Health. Care (2006)
- Utility measurement in healthcare: the things I never got to. Torrance, G.W. Pharmacoeconomics (2006)
- Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate. Torrance, G.W., Tugwell, P., Amorosi, S., Chartash, E., Sengupta, N. Rheumatology. (Oxford) (2004)
- Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function. Torrance, G.W., Keresteci, M.A., Casey, R.W., Rosner, A.J., Ryan, N., Breton, M.C. Qual. Life. Res (2004)
- Switching therapy in health economics trials: confronting the confusion. Torrance, G.W., Drummond, M.F., Walker, V. Med. Decis. Making (2003)
- Health utility estimation. Torrance, G.W., Furlong, W., Feeny, D. Expert. Rev. Pharmacoecon. Outcomes. Res (2002)
- Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Torrance, G.W., Blaker, D., Detsky, A., Kennedy, W., Schubert, F., Menon, D., Tugwell, P., Konchak, R., Hubbard, E., Firestone, T. Pharmacoeconomics (1996)